Cite
Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and Anticipation of Human Efficacious Doses.
MLA
Yao, Ye, et al. “Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and Anticipation of Human Efficacious Doses.” Journal of Pharmaceutical Sciences, vol. 109, no. 2, Feb. 2020, pp. 1169–77. EBSCOhost, https://doi.org/10.1016/j.xphs.2019.10.035.
APA
Yao, Y., Yao, Q., Fu, Y., Tian, X., An, Q., Yang, L., Su, H., Lu, W., Hao, C., & Zhou, T. (2020). Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and Anticipation of Human Efficacious Doses. Journal of Pharmaceutical Sciences, 109(2), 1169–1177. https://doi.org/10.1016/j.xphs.2019.10.035
Chicago
Yao, Ye, Qingyu Yao, Yu Fu, Xiuyun Tian, Qiming An, Liang Yang, Hong Su, Wei Lu, Chunyi Hao, and Tianyan Zhou. 2020. “Pharmacokinetic/Pharmacodynamic Modeling of the Anti-Cancer Effect of Dexamethasone in Pancreatic Cancer Xenografts and Anticipation of Human Efficacious Doses.” Journal of Pharmaceutical Sciences 109 (2): 1169–77. doi:10.1016/j.xphs.2019.10.035.